Treatment and prognostic variables of Ewing’s sarcoma family tumors cohort
Variable | Total (n=12) | Patients with event (n=6) | Patients without event (n=6) | |
---|---|---|---|---|
Metastatic disease | 6 (50.0%) | 6 (100.0%) | 0 | 0.0022 |
Lung mets | 5 (42.0%) | 5 (83.0%) | ||
Chemotherapy | 12 (100.0%) | 6 (100.0%) | 6 (100.0%) | 1.0000 |
Limb salvage surgery | 8 (66.7%) | 4 (66.6%) | 4 (66.6%) | 0.4545 |
Negative microscopic margins | 5 (42.0%) | 3 (50.0%) | 2 (33.3%) | 0.6104 |
Tumor necrosis >90% | 7 (58.3%) | 4 (66.6%) | 3 (50.0%) | 1.0000 |
Radiotherapy | 12 (100.0%) | 6 (100.0%) | 6 (100.0%) | |
Functional disability at follow-up | 2 (16.7%) | 1 (16.7%) | 1 (16.7%) | 1.0000 |
Death | 4 (25.0%) | 4 (66.6%) | 0 | 0.0606 |
Disease progression as cause of death | 4 (25.0%) | 4 (66.6%) | 0 | 0.066 |